Core Viewpoint - Anhui Wanbang Pharmaceutical Technology Co., Ltd. plans to use part of its raised funds to repurchase shares, with a total amount ranging from 15 million to 30 million yuan, aimed at employee stock ownership plans or equity incentive plans [1] Group 1 - The company will repurchase shares at a price not exceeding 60.62 yuan per share, which will be adjusted to a maximum of 60.27 yuan per share after the rights distribution on January 24, 2025 [1] - The company is required to disclose the progress of the repurchase within the first three trading days of each month [1] - The repurchase plan complies with relevant regulations and the company's own guidelines, including the Shenzhen Stock Exchange's self-regulatory guidelines [1] Group 2 - The company will execute the repurchase within a 12-month period from the date the board approved the plan, based on market conditions [1] - The company will fulfill its information disclosure obligations in a timely manner [1]
安徽万邦医药拟斥1500万-3000万元回购股份 用于股权激励或员工持股